Status:

NOT_YET_RECRUITING

Permanent Supportive Housing Overdose Prevention-2 Study

Lead Sponsor:

NYU Langone Health

Collaborating Sponsors:

National Institute on Drug Abuse (NIDA)

Conditions:

Overdose

Substance Use

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This community-partnered study examines a technical assistance intervention designed to help permanent supportive housing agencies implement evidence-based practices to prevent tenant overdose and imp...

Detailed Description

Homelessness and housing instability are strongly linked with overdose risk. Permanent supportive housing (PSH) -subsidized housing paired with supportive services-is a key strategy to end homelessnes...

Eligibility Criteria

Inclusion

  • We will be enrolling supportive housing agencies from NY and NJ to participate in this study. Trial enrollment and intervention delivery will occur at the level of the agency. There are anticipated to be 24 supportive housing agencies total that will be enrolled in the study; approximately 6 agencies will be randomly assigned to each of the four intervention waves in the stepped wedge randomized controlled trial.
  • Supportive Housing Agencies/Individuals who Work at Supportive Housing Agencies:
  • Serve at least 40 tenants in New York and/or New Jersey
  • Have a significant concern for overdose (as demonstrated by past year tenant overdose)
  • Be willing to complete all activities required for participation in the trial
  • Tenants who Live in Supportive Housing Agencies:
  • Must live in an enrolled Supportive Housing Agency
  • Must be 18 years and older

Exclusion

  • See inclusion criteria.

Key Trial Info

Start Date :

July 1 2027

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 31 2031

Estimated Enrollment :

2940 Patients enrolled

Trial Details

Trial ID

NCT07214519

Start Date

July 1 2027

End Date

March 31 2031

Last Update

October 20 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

NYU Langone Health

New York, New York, United States, 10016

Permanent Supportive Housing Overdose Prevention-2 Study | DecenTrialz